Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Han Yao

Showing results (231-240 of 271) with videos related to

Pageof 28
Sort By:
World Journal of Gastroenterology|January 15, 2025
Trends of alkaline phosphatase to prealbumin ratio in patients with hepatitis B linked to hepatocellular carcinoma developmentWen-Chong Zhen, Jing Sun, Xue-Ting Bai, et al.
The American Journal of Clinical Nutrition|January 9, 2007
Multivitamin/Mineral supplements and prevention of chronic disease: executive summaryHan-Yao Huang, Benjamin Caballero, Stephanie Chang, et al.
Nature Biomedical Engineering|April 7, 2019
Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumoursHan Yao, Jiang Lan, Chushu Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2007
Measurement of cyclin E genomic copy number and strand length in cell-free DNA distinguish malignant versus benign effusionsRitu Salani, Ben Davidson, Michael Fiegl, et al.
Nature Biomedical Engineering|April 13, 2019
Author Correction: Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumoursHan Yao, Jiang Lan, Chushu Li, et al.
European Journal of Cancer (Oxford, England : 1990)|July 7, 2019
Incidence of hepatitis B reactivation during epidermal growth factor receptor tyrosine kinase inhibitor treatment in non-small-cell lung cancer patientsZong-Han Yao, Wei-Yu Liao, Chao-Chi Ho, et al.
The Oncologist|May 17, 2017
Real-World Data on Prognostic Factors for Overall Survival in EGFR Mutation-Positive Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line GefitinibZong-Han Yao, Wei-Yu Liao, Chao-Chi Ho, et al.
Annals of Internal Medicine|August 2, 2006
The efficacy and safety of multivitamin and mineral supplement use to prevent cancer and chronic disease in adults: a systematic review for a National Institutes of Health state-of-the-science conferenceHan-Yao Huang, Benjamin Caballero, Stephanie Chang, et al.
BMC Public Health|August 15, 2025
Association between e-cigarette use and COVID-19 diagnosis: a systematic review and meta-analysisYing Xie, Xinmei Zhou, Dengmin Huang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 8, 2025
Inhibition of IRE-1α Alleviates Pyroptosis and Metabolic Dysfunction-Associated Steatohepatitis by Suppressing Gasdermin DXin Zeng, Tian Wu, Qing Xu, et al.
Pageof 28

Showing results (231-240 of 271) with videos related to

Sort By:
Pageof 28
World Journal of Gastroenterology|January 15, 2025
Trends of alkaline phosphatase to prealbumin ratio in patients with hepatitis B linked to hepatocellular carcinoma developmentWen-Chong Zhen, Jing Sun, Xue-Ting Bai, et al.
The American Journal of Clinical Nutrition|January 9, 2007
Multivitamin/Mineral supplements and prevention of chronic disease: executive summaryHan-Yao Huang, Benjamin Caballero, Stephanie Chang, et al.
Nature Biomedical Engineering|April 7, 2019
Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumoursHan Yao, Jiang Lan, Chushu Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2007
Measurement of cyclin E genomic copy number and strand length in cell-free DNA distinguish malignant versus benign effusionsRitu Salani, Ben Davidson, Michael Fiegl, et al.
Nature Biomedical Engineering|April 13, 2019
Author Correction: Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumoursHan Yao, Jiang Lan, Chushu Li, et al.
European Journal of Cancer (Oxford, England : 1990)|July 7, 2019
Incidence of hepatitis B reactivation during epidermal growth factor receptor tyrosine kinase inhibitor treatment in non-small-cell lung cancer patientsZong-Han Yao, Wei-Yu Liao, Chao-Chi Ho, et al.
The Oncologist|May 17, 2017
Real-World Data on Prognostic Factors for Overall Survival in EGFR Mutation-Positive Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line GefitinibZong-Han Yao, Wei-Yu Liao, Chao-Chi Ho, et al.
Annals of Internal Medicine|August 2, 2006
The efficacy and safety of multivitamin and mineral supplement use to prevent cancer and chronic disease in adults: a systematic review for a National Institutes of Health state-of-the-science conferenceHan-Yao Huang, Benjamin Caballero, Stephanie Chang, et al.
BMC Public Health|August 15, 2025
Association between e-cigarette use and COVID-19 diagnosis: a systematic review and meta-analysisYing Xie, Xinmei Zhou, Dengmin Huang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 8, 2025
Inhibition of IRE-1α Alleviates Pyroptosis and Metabolic Dysfunction-Associated Steatohepatitis by Suppressing Gasdermin DXin Zeng, Tian Wu, Qing Xu, et al.
Pageof 28